Blog

Tillis, Budd introduce EPIC Act in the Senate

Sen. Thom Tillis (R-NC) and Sen. Ted Budd (R-NC) have joined their colleague in North Carolina's House delegation in recognizing the harm caused by the Inflation Reduction Act's penalty for small-molecule drug. They have introduced the bipartisan Ensuring Pathways to Innovative Cures Act in the... Continue Reading

Murphy, Davis, Hudson reintroduce EPIC Act to elminate "pill penalty"

Rep. Greg Murphy, M.D., (R-NC); Rep. Don Davis (D-NC); and Rep. Richard Hudson (R-NC) have recognized the harm in penalizing small-molecule drug and have reintroduced the bipartisan Ensuring Pathways to Innovative Cures Act to be considered by the 119th Congress. The EPIC Act simply equalizes the... Continue Reading

Cutting-edge cancer tests to be available to military, their families

Thanks in no small part to the support of North Carolina’s Congressional delegation, multicancer early detection testing now will be available to active-duty military, National Guard and Reserve members, retirees and their families. North Carolina has one of the largest active-duty... Continue Reading

NCLifeSci supports university research, opposes NIH guidance cutting funds  

The North Carolina Life Sciences Organization strongly values the role university research plays in driving the creation of new life sciences companies, groundbreaking medicines and transformative treatments. We recognize that North Carolina's vibrant life sciences ecosystem is built upon a... Continue Reading

NC treasurer: NC hospitals use 340B to profit a patient’s expense

A new report from the North Carolina State Treasurer found North Carolina hospitals use the federal 340B program to profit at the expense of patients, teachers and state employees. Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to... Continue Reading

Startups struggle with new R&D tax rule

A 2022 tax rule requiring the amortization of research and development expenses has created significant challenges for many life sciences startups and small businesses. Previously, grant money received by these companies and spent on R&D could be deducted immediately in full, but the new rule... Continue Reading

AMR is a silent killer that threatens our health in North Carolina and beyond

The small red bump on my son's hand looked at first like a bug bite. But when the hand swelled to the point of immobility and we took him to the doctor, the diagnosis was MRSA, an infection from a type of staph bacteria resistant to the family of antibiotics usually prescribed as... Continue Reading

Study projects extensive damage to drug development, jobs from drug-pricing policies

A new study estimates that there would be 237 fewer FDA approvals of new medicines over the next decade and 1.1 million lost jobs if proposals to expand government-mandated drug pricing policies are implemented. The policies include allowing Medicare to set prices for specific drugs five years... Continue Reading

Collaboration and statewide support make North Carolina a thriving hub of urgently needed innovation

The rarest day on the calendar is the one that does not even occur in every year: February 29. In 2008, this was designated as Rare Disease Day and since then, the last day of February has been an opportunity to draw attention to, honor and support people living with these... Continue Reading

Part D drug price “negotiation” comes at cost of jobs, investment, cures 

Part D drug price “negotiation” comes at cost of jobs, investment, cures Update: The House passed the Inflation Reduction Act on Friday, Aug. 12. This past weekend, the U.S. Senate passed the Inflation Reduction Act. Included in the law is a provision that gives... Continue Reading

CMS decision not to cover Alzheimer’s treatment a bad one

NCBIO stands in solidarity with patient advocates and industry leaders in opposing the Centers for Medicare and Medicaid Services’ draft proposal to restrict coverage for current and future Alzheimer's drugs targeting beta amyloid, a known hallmark of the disease. Restricting coverage is a... Continue Reading

Pharmaceutical Prescribing Labels: An Enormous Opportunity to Eliminate Pointless Paper Waste in the

This post originally appeared on the website of the Environmental Paper Network. A serious approach to addressing climate change must include the proactive elimination of unnecessary paper consumption. Paper is an important and useful material that should be produced and consumed in a... Continue Reading